KROS
Price
$17.50
Change
+$0.18 (+1.04%)
Updated
Nov 26 closing price
Capitalization
533.16M
97 days until earnings call
Intraday BUY SELL Signals
LVTX
Price
$1.74
Change
-$0.07 (-3.87%)
Updated
Nov 20 closing price
Capitalization
45.77M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KROS vs LVTX

Header iconKROS vs LVTX Comparison
Open Charts KROS vs LVTXBanner chart's image
Keros Therapeutics
Price$17.50
Change+$0.18 (+1.04%)
Volume$1.66M
Capitalization533.16M
LAVA Therapeutics
Price$1.74
Change-$0.07 (-3.87%)
Volume$285.52K
Capitalization45.77M
KROS vs LVTX Comparison Chart in %
KROS
Daily Signal:
Gain/Loss:
LVTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KROS vs. LVTX commentary
Nov 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a StrongBuy and LVTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 27, 2025
Stock price -- (KROS: $17.50 vs. LVTX: $1.74)
Brand notoriety: KROS and LVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 150% vs. LVTX: 86%
Market capitalization -- KROS: $533.16M vs. LVTX: $45.77M
KROS [@Biotechnology] is valued at $533.16M. LVTX’s [@Biotechnology] market capitalization is $45.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 0 FA rating(s) are green whileLVTX’s FA Score has 1 green FA rating(s).

  • KROS’s FA Score: 0 green, 5 red.
  • LVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, LVTX is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 6 TA indicator(s) are bullish while LVTX’s TA Score has 6 bullish TA indicator(s).

  • KROS’s TA Score: 6 bullish, 4 bearish.
  • LVTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both KROS and LVTX are a good buy in the short-term.

Price Growth

KROS (@Biotechnology) experienced а +3.80% price change this week, while LVTX (@Biotechnology) price change was -3.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -1.24%, and the average quarterly price growth was +71.95%.

Reported Earning Dates

KROS is expected to report earnings on Mar 04, 2026.

LVTX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($533M) has a higher market cap than LVTX($45.8M). LVTX YTD gains are higher at: 82.965 vs. KROS (10.550). KROS has higher annual earnings (EBITDA): 25.5M vs. LVTX (-26.85M). KROS has more cash in the bank: 690M vs. LVTX (56.2M). LVTX has less debt than KROS: LVTX (0) vs KROS (18M). KROS has higher revenues than LVTX: KROS (233M) vs LVTX (4.99M).
KROSLVTXKROS / LVTX
Capitalization533M45.8M1,164%
EBITDA25.5M-26.85M-95%
Gain YTD10.55082.96513%
P/E Ratio11.22N/A-
Revenue233M4.99M4,669%
Total Cash690M56.2M1,228%
Total Debt18M0-
TECHNICAL ANALYSIS
Technical Analysis
KROSLVTX
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 22 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signal:
Gain/Loss:
LVTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCCMY2.46N/A
N/A
BAIC MTR CORP LTD
BLHK31.10N/A
N/A
BlueHarbor Bank (Mooresville NC)
AFSIM15.50N/A
N/A
AmTrust Financial Services, Inc.
HEEVF0.12N/A
N/A
HELIUM EVOLUTION INC.
CPCAY7.56-0.08
-1.05%
Cathay Pacific Airways, Ltd.

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+1.04%
INO - KROS
52%
Loosely correlated
+8.29%
AXON - KROS
43%
Loosely correlated
+0.81%
RAPT - KROS
39%
Loosely correlated
+10.91%
DNLI - KROS
39%
Loosely correlated
+1.49%
ALT - KROS
39%
Loosely correlated
+0.68%
More